Application of heptamethine indocyanine small molecules with N-alkyl side chains with different chain lengths in preparation of photosensitizer for treating tumors

An indocyanine and small molecule technology, applied in the field of biomedical engineering, can solve the problems of remote metastatic tumor immunotherapy research, unsatisfactory phototherapy effect, and practical application limitations without phototherapy to activate the body's systemic anti-tumor immune response. , to amplify the immunogenic death of tumor cells, inhibit tumor growth, and enhance the effect of phototherapy

Pending Publication Date: 2022-06-28
ARMY MEDICAL UNIV
0 Cites 0 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0006] However, due to its strong hydrophobicity, it is easy to aggregate and precipitate in the water environment, and the phototherapy effect of most heptacyanine small molecule photosensitizers is not ideal, and its practical application is also greatly limited.
More importantly, previous studies on small...
View more

Method used

[0050] A Balb/c mouse (female) subcutaneous tumor-bearing model was established using 4T1 cells. Compounds C3-C11 with different chain lengths were administered at 0.25 mg/kg via the tail vein, and a small animal in vivo imaging system (Trilogy, Gene Co., Ltd) was used for near-infrared fluorescence real-time imaging to observe the metabolism of compounds in mice at d...
View more

Abstract

The invention relates to application of heptamethine indocyanine small molecules with N-alkyl side chains with different chain lengths in preparation of a photosensitizer for treating tumors. According to the application, self anti-tumor immune response is activated through tumor phototherapy. The photosensitizer has a good tumor preferential accumulation characteristic, accurate phototherapy guided by near-infrared imaging and tumor in-situ induced anti-tumor immune response, does not need to additionally take immunotherapy drugs, and has a bright application prospect in tumor targeted immunotherapy.

Application Domain

Photodynamic therapyIn-vivo testing preparations +1

Technology Topic

Tumor targetPhotosens +11

Image

  • Application of heptamethine indocyanine small molecules with N-alkyl side chains with different chain lengths in preparation of photosensitizer for treating tumors
  • Application of heptamethine indocyanine small molecules with N-alkyl side chains with different chain lengths in preparation of photosensitizer for treating tumors
  • Application of heptamethine indocyanine small molecules with N-alkyl side chains with different chain lengths in preparation of photosensitizer for treating tumors

Examples

  • Experimental program(6)

Example Embodiment

[0034] Example 1 Spectroscopic determination of small molecules C3-C11 of heptacyanine with different chain lengths
[0035] Accurately weigh the small molecules C3-C11 of heptamethine indocyanine with different chain lengths with a 1/10,000 analytical balance, and prepare a 10 mM dimethyl sulfoxide (DMSO) solution for later use. During the test, the dye solution was diluted to 4 μM with DMSO, and the UV absorption spectrum, fluorescence emission spectrum and fluorescence quantum yield (Φ) of compounds C3-C11 were measured by ShimadzuUV-3600 UV-Fluorescence Spectrophotometer and Lumina Fluorescence Spectrometer respectively. F). As shown in Table 1, the test results show that the maximum ultraviolet absorption wavelength and maximum fluorescence emission wavelength of all compounds are located in the near-infrared region (700-900nm), and the molar absorption coefficient (ε) is in the range of 100 000-350 000, showing excellent Light Harvesting Capability and Fluorescence Emission Properties.
[0036] Table 1 UV absorption and fluorescence properties of compounds C3~C11
[0037]
[0038] In the solution containing human serum albumin (1% HSA), it was found that the fluorescence of C3 to C11 was significantly enhanced; especially, the fluorescence enhancement of C8 was the most significant, suggesting that the strongest binding to human serum albumin HSA ( figure 1 ). Through transmission electron microscopy, it was unexpectedly found that the small molecules of heptacyanine with different chain lengths C3-C11 and HSA formed nanoparticles of different sizes, especially C8, which self-assembled in 1% HSA aqueous solution to form the most uniform size nano-dye-albumin complex (Table 2). Through the docking of HSA protein and small molecules, the potential mechanism was further explored. It was found that the minimum energy (-10.8kcal/mol) required for the binding of C8 and HSA protein, so molecule-protein binding was easy to occur, and it was beneficial to mediate the subsequent small molecules. Nanoscale self-assembly between molecules and HSA proteins (Table 2).
[0039] Table 2 Nano self-assembly of compounds C3~C11 in 1% HSA
[0040]

Example Embodiment

[0041] Example 2 Photothermal effects of small molecules C3-C11 of heptacyanine with different chain lengths
[0042] Compounds C3 to C11 were prepared as 10 mM stock solutions with DMSO and stored at -20°C. A certain amount of stock solution was drawn from the stock solutions of C3-C11 compounds prepared above and added to phosphate buffered saline (PBS, 10mM, PH=7.4) containing 1% HSA to prepare a 10 μM sample working solution, and 1.5 mL of each was added. in a centrifuge tube. Place the centrifuge tube containing the detection solution at 808nm, 1.0W/cm 2 The near-infrared laser (Laser) was irradiated for 5 minutes, and the temperature change was recorded every 30 seconds. The results are shown in figure 2 and image 3. The experimental results show that compounds C3-C11 have the effect of inducing temperature rise, among which the temperature rise effect of C8 is the most excellent, which can reach above 55℃.

Example Embodiment

[0043] Example 3 Singlet Oxygen Generation of Heptamethanine Small Molecules C3~C11 with Different Chain Lengths
[0044] SOSG probes (prepared in 100% methanol solution) were added to 2 mL of 10 μM aqueous solution of heptamethanine small molecules with different chain lengths, so that the SOSG concentration was 1.5 μM and the methanol content was 2%. and then at 1W/cm 2 The 808 nm laser was irradiated for 5 minutes, followed by excitation at 495 nm, and the fluorescence emission spectrum at 500-600 nm was immediately measured, and the generation of singlet oxygen was quantified by the fluorescence intensity of the maximum emission peak at 525 nm. like Figure 4 As shown, C3-C11 can generate a large amount of singlet oxygen after being irradiated by near-infrared 808 nm laser, among which compound C8 has the strongest singlet oxygen generation ability, which provides feasibility for realizing tumor photodynamic therapy.

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Application of GSK126 in preparation of medicine for treating oxaliplatin drug-resistant colon cancer

PendingCN114159441Apromote apoptosisinhibit tumor growth
Owner:CENT SOUTH UNIV

Heterogeneous CIC cell model of targeted adhesion molecule and preparation method thereof

PendingCN114686439APromote immune killinginhibit tumor growth
Owner:ACADEMY OF MILITARY MEDICAL SCI

Magnesium alloy bone splint capable of resisting bacteria and inhibiting tumor proliferation and preparation method

InactiveCN113430438Agood antibacterial propertiesinhibit tumor growth
Owner:INST OF MEDICINE & HEALTH GUANGDONG ACAD OF SCI +1

Application of ERBB4 in gastric cancer treatment aspect

ActiveCN109061188Ainhibit tumor growthSignificant increase in sensitivity
Owner:SUN YAT SEN UNIV CANCER CENT

Immune-enhanced exosome hydrogel compound as well as preparation method and application thereof

ActiveCN112933113Aincrease savingsImprove dispersion stability
Owner:AFFILIATED HOSPITAL OF JIANGNAN UNIV

Drug delivery system modified with functionalized cell-penetrating peptide

PendingCN110772645Agood biosecurityincrease savings
Owner:FUDAN UNIV +1

CAR-T cell targeting AXL and preparation method and application thereof

PendingCN114075548Ainhibit tumor growthsuppress drug resistance
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV

Classification and recommendation of technical efficacy words

  • increase savings

Drug delivery system modified with functionalized cell-penetrating peptide

PendingCN110772645Agood biosecurityincrease savings
Owner:FUDAN UNIV +1

Immune-enhanced exosome hydrogel compound as well as preparation method and application thereof

ActiveCN112933113Aincrease savingsImprove dispersion stability
Owner:AFFILIATED HOSPITAL OF JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products